{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:50:58Z","timestamp":1791665458357,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100032413","name":"Nordic Bioscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["4366-00005A"],"award-info":[{"award-number":["4366-00005A"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.joca.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:24:16Z","timestamp":1789971856000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can obesity pharmacotherapy modify osteoarthritis? Interpreting pain relief, weight-loss quality, and structural outcomes"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-7037","authenticated-orcid":false,"given":"Joscha","family":"Rombach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-6832","authenticated-orcid":false,"given":"Monica T.","family":"Hannani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-0093","authenticated-orcid":false,"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6944-1731","authenticated-orcid":false,"given":"Asger Reinstrup","family":"Bihlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2784-2138","authenticated-orcid":false,"given":"Mayuur","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8944-2512","authenticated-orcid":false,"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-9297","authenticated-orcid":false,"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-1417","authenticated-orcid":false,"given":"Christian S.","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-8740","authenticated-orcid":false,"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2026.09.007_bib1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.39707","article-title":"Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study","volume":"68","author":"Reyes","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/osp4.398","article-title":"Association of body mass index and osteoarthritis with healthcare expenditures and utilization","volume":"6","author":"Johnston","year":"2020","journal-title":"Obes. Sci. Pract."},{"key":"10.1016\/j.joca.2026.09.007_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/acr.20464","article-title":"What if we prevent obesity? Risk reduction in knee osteoarthritis estimated through a meta-analysis of observational studies","volume":"63","author":"Muthuri","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.joca.2026.09.007_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/504189","article-title":"The effects of bariatric surgery weight loss on knee pain in patients with osteoarthritis of the Knee","volume":"2012","author":"Edwards","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.joca.2026.09.007_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.2013.277669","article-title":"Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial","volume":"310","author":"Messier","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2026.09.007_bib6","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib7","unstructured":"Eli Lilly and Company Press Release. Lilly\u2019s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial. Press Release 2025. https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-triple-agonist-retatrutide-delivered-weight-loss-average (accessed April 14, 2026)."},{"key":"10.1016\/j.joca.2026.09.007_bib8","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib9","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction\u2013Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib11","first-page":"0319","article-title":"Glucagon-like peptide-1 receptor agonists in management of knee osteoarthritis: a meta-analysis","author":"Madison","year":"2025","journal-title":"ACR Converg."},{"key":"10.1016\/j.joca.2026.09.007_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/annrheumdis-2020-219181","article-title":"Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study","volume":"80","author":"Eckstein","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.09.007_bib13","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.joca.2017.01.006","article-title":"Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients","volume":"25","author":"Arends","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.09.007_bib14","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.arth.2024.06.008","article-title":"The five-year incidence of progression to osteoarthritis and total joint arthroplasty in patients prescribed glucagon-like peptide 1 receptor agonists","volume":"39","author":"Lavu","year":"2024","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.joca.2026.09.007_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/23259671241297157","article-title":"The impact of contemporary glucagon-like peptide-1 receptor agonists on the onset, severity, and conversion to arthroplasty in hip and knee osteoarthritis","volume":"13","author":"Porto","year":"2025","journal-title":"Orthop. J. Sports Med."},{"key":"10.1016\/j.joca.2026.09.007_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100567","article-title":"Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: a systematic review of pre-clinical and human studies","volume":"7","author":"Cheng","year":"2025","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.joca.2026.09.007_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1126\/science.adt0548","article-title":"Osteoarthritis treatment via the GLP-1\u2013mediated gut-joint axis targets intestinal FXR signaling","volume":"388","author":"Yang","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.joca.2026.09.007_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100677","article-title":"Biochemical biomarkers of knee osteoarthritis progression: Results from the FNIH biomarkers consortium progress OA study","volume":"7","author":"Collins","year":"2025","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.joca.2026.09.007_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","article-title":"Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium","volume":"76","author":"Kraus","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.09.007_bib20","author":"U.S. Food and Drug Administration","year":"2025","journal-title":"Obesity Overweight Developing Drugs Biological Products Weight Reduction Guidance Industry DRAFT GUIDANCE"},{"key":"10.1016\/j.joca.2026.09.007_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.joca.2026.09.007_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.joca.2024.02.003","article-title":"Obesity and body mass index: Past and future considerations in osteoarthritis research","volume":"32","author":"Godziuk","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.09.007_bib23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12891-023-06663-9","article-title":"Post-traumatic osteoarthritis: the worst associated injuries and differences in patients\u2019 profile when compared with primary osteoarthritis","volume":"24","author":"Maia","year":"2023","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.joca.2026.09.007_bib24","first-page":"38747","article-title":"A review of Risk Factors for Post-traumatic hip and knee osteoarthritis following musculoskeletal injuries other than anterior cruciate ligament rupture","volume":"14","author":"Betancourt","year":"2022","journal-title":"Orthop. Rev."},{"key":"10.1016\/j.joca.2026.09.007_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnesp.2025.11.143","article-title":"Sarcopenic obesity prevalence and clinical implications in patients with advanced knee osteoarthritis and class II-III obesity","volume":"72","author":"Godziuk","year":"2026","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.joca.2026.09.007_bib26","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1111\/dom.16379","article-title":"The Goldilocks for chronic weight management-Balancing quantity with quality of weight loss","volume":"27","author":"Henriksen","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.joca.2026.09.007_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41413-025-00483-4","article-title":"Weight loss induced bone loss: mechanism of action and clinical implications","volume":"13","author":"Liu","year":"2025","journal-title":"Bone Res."},{"key":"10.1016\/j.joca.2026.09.007_bib28","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/jcm12041532","article-title":"Prevalence of Sarcopenia in Knee Osteoarthritis: A Systematic Review and Meta-Analysis","volume":"12","author":"Pegreffi","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2024.100489","article-title":"Association between sarcopenic obesity and knee osteoarthritis: a narrative review","volume":"6","author":"Balogun","year":"2024","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.joca.2026.09.007_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41598-023-50528-z","article-title":"Association between sarcopenia and osteoarthritis among the US adults: a cross-sectional study","volume":"14","author":"Peng","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.joca.2026.09.007_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s40001-023-01322-0","article-title":"Causal relationship between sarcopenia and osteoarthritis: a bi-directional two-sample mendelian randomized study","volume":"28","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.joca.2026.09.007_bib32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/art.43213","article-title":"Longitudinal associations between baseline sarcopenia and knee osteoarthritis progression and risk of knee replacement","volume":"77","author":"Wu","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2026.09.007_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103796","article-title":"Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression","volume":"93","author":"Budini","year":"2026","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.joca.2026.09.007_bib35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.joca.2022.10.023","article-title":"Association between weight gain and knee osteoarthritis: a systematic review","volume":"31","author":"Solanki","year":"2023","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.09.007_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/art.40692","article-title":"Risk of Knee Osteoarthritis With Obesity, Sarcopenic Obesity, and Sarcopenia","volume":"71","author":"Misra","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41366-021-01046-3","article-title":"Weight loss is associated with reduced risk of knee and hip replacement: a survival analysis using Osteoarthritis Initiative data","volume":"46","author":"Salis","year":"2022","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.joca.2026.09.007_bib38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41366-021-00832-3","article-title":"Does weight loss reduce the incidence of total knee and hip replacement for osteoarthritis?\u2014A prospective cohort study among middle-aged and older adults with overweight or obesity","volume":"45","author":"Jin","year":"2021","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.joca.2026.09.007_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1249\/MSS.0000000000001074","article-title":"Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity","volume":"49","author":"Weiss","year":"2017","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.joca.2026.09.007_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1148\/radiol.2017161005","article-title":"Is weight loss associated with less progression of changes in knee articular cartilage among obese and overweight patients as assessed with mr imaging over 48 months? data from the osteoarthritis initiative","volume":"284","author":"Gersing","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.joca.2026.09.007_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14737159.2024.2315282","article-title":"From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers","volume":"24","author":"Hannani","year":"2024","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.joca.2026.09.007_bib42","article-title":"The expanding benefits of GLP-1 medicines","volume":"6","author":"Gonzalez-Rellan","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-00678-2","article-title":"The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile","volume":"21","author":"Larsen","year":"2021","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.joca.2026.09.007_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-024-03361-2","article-title":"The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection \u2013 a novel disease-modifying osteoarthritis drug","volume":"26","author":"Mohamed","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.joca.2026.09.007_bib45","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/acr.25101","article-title":"Core Recommendations for Osteoarthritis Care: A Systematic Review of Clinical Practice Guidelines","volume":"75","author":"Conley","year":"2023","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.joca.2026.09.007_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/JPR.S55598","article-title":"The association between chronic pain and obesity","volume":"8","author":"Okifuji","year":"2015","journal-title":"J. Pain. Res."},{"key":"10.1016\/j.joca.2026.09.007_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-024-01143-3","article-title":"The role of obesity and adipose tissue dysfunction in osteoarthritis pain","volume":"20","author":"Binvignat","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib48","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpain.2006.12.003","article-title":"Comorbidity of Obesity and Pain in a General Population: Results from the Southern Pain Prevalence Study","volume":"8","author":"Hitt","year":"2007","journal-title":"J. Pain."},{"key":"10.1016\/j.joca.2026.09.007_bib49","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ejp.1019","article-title":"Body mass index and distribution of body fat can influence sensory detection and pain sensitivity","volume":"21","author":"Tashani","year":"2017","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.joca.2026.09.007_bib50","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.mayocp.2020.03.025","article-title":"Central obesity is associated with neuropathy in the severely obese","volume":"95","author":"Callaghan","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.joca.2026.09.007_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/AAP.0000000000000218","article-title":"Obesity and Chronic Pain: Systematic Review of Prevalence and Implications for Pain Practice","volume":"40","author":"Narouze","year":"2015","journal-title":"Reg. Anesth. Pain. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/pubmed\/fdv040","article-title":"Who are the obese? A cluster analysis exploring subgroups of the obese","volume":"38","author":"Green","year":"2016","journal-title":"J. Public. Health (Bangk. )"},{"key":"10.1016\/j.joca.2026.09.007_bib53","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/oby.2011.397","article-title":"Obesity and pain are associated in the United States","volume":"20","author":"Stone","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.joca.2026.09.007_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1274356","article-title":"Effects of weight loss through dietary intervention on pain characteristics, functional mobility, and inflammation in adults with elevated adiposity","volume":"11","author":"Ward","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.joca.2026.09.007_bib55","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jpain.2017.08.004","article-title":"Improvement in the Spatial Distribution of Pain, Somatic Symptoms, and Depression After a Weight Loss Intervention","volume":"18","author":"Schrepf","year":"2017","journal-title":"J. Pain."},{"key":"10.1016\/j.joca.2026.09.007_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2022.798995","article-title":"The obese brain: mechanisms of systemic and local inflammation, and interventions to reverse the cognitive deficit","volume":"16","author":"Salas-Venegas","year":"2022","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.joca.2026.09.007_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/biomedicines14010058","article-title":"Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies","volume":"14","author":"McKenzie","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.joca.2026.09.007_bib58","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/09593985.2024.2372381","article-title":"Association between widespread pain and psychosocial factors in people with knee osteoarthritis: a cross-sectional study of patients from primary care in Denmark","volume":"41","author":"Peral P\u00e9rez","year":"2024","journal-title":"Physiother. Theory Pract."},{"key":"10.1016\/j.joca.2026.09.007_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tem.2021.10.005","article-title":"The menace of obesity to depression and anxiety prevalence","volume":"33","author":"Fulton","year":"2022","journal-title":"Trends Endocrinol. & Metab."},{"key":"10.1016\/j.joca.2026.09.007_bib60","first-page":"662","article-title":"Determination of Pain Phenotypes in Knee Osteoarthritis Using Latent Profile Analysis","volume":"22","author":"Kittelson","year":"2020","journal-title":"Pain. Med."},{"key":"10.1016\/j.joca.2026.09.007_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.joca.2026.09.007_bib62","first-page":"121","article-title":"Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: A new opportunity?","volume":"32","author":"Meurot","year":"2022","journal-title":"J. Orthop. Transl."},{"key":"10.1016\/j.joca.2026.09.007_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12950-019-0218-y","article-title":"The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA\/CREB pathway in a rat model of knee osteoarthritis","volume":"16","author":"Que","year":"2019","journal-title":"J. Inflamm."},{"key":"10.1016\/j.joca.2026.09.007_bib64","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ajcn\/nqaa328","article-title":"Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: A randomized controlled trial","volume":"113","author":"Gudbergsen","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.joca.2026.09.007_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/EJE-06-0716","article-title":"Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women","volume":"157","author":"Bull\u00f3","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.joca.2026.09.007_bib66","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2147\/JPR.S247472","article-title":"Nerve Growth Factor Signaling and Its Contribution to Pain","volume":"13","author":"Barker","year":"2020","journal-title":"J. Pain. Res."},{"key":"10.1016\/j.joca.2026.09.007_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/BOR.0000000000000354","article-title":"Nerve growth factor blockade for the management of osteoarthritis pain: What can we learn from clinical trials and preclinical models?","volume":"29","author":"Miller","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib68","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.joca.2018.12.001","article-title":"Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients","volume":"27","author":"Karsdal","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.09.007_bib69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s40122-022-00384-y","article-title":"Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies","volume":"11","author":"Miki","year":"2022","journal-title":"Pain. Ther."},{"key":"10.1016\/j.joca.2026.09.007_bib70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41584-023-01021-4","article-title":"Placebo effects in osteoarthritis: implications for treatment and drug development","volume":"19","author":"Neogi","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100684","article-title":"The relationship between circulating and tissue biomarkers and OA-related pain: A systematic literature review","volume":"7","author":"Mathieu","year":"2025","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.joca.2026.09.007_bib72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroimage.2015.08.060","article-title":"Pain inhibits pain; human brainstem mechanisms","volume":"124","author":"Youssef","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.joca.2026.09.007_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2022.100262","article-title":"Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status?","volume":"4","author":"Karsdal","year":"2022","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.joca.2026.09.007_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.645842","article-title":"New Trends in Pharmacological Treatments for Osteoarthritis","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.joca.2026.09.007_bib75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41927-026-00628-w","article-title":"Weight loss ameliorates symptoms of osteoarthritis and is correlated with alterations in soluble bone and cartilage markers: an analysis of patient-reported outcomes and biomarkers","volume":"10","author":"Bay-Jensen","year":"2026","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.joca.2026.09.007_bib76","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(24)00163-3","article-title":"Bone health in adults with obesity before and after interventions to promote weight loss","volume":"12","author":"Paccou","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.joca.2026.09.007_bib77","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard-2023-223845","article-title":"Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort","volume":"82","author":"Zhu","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.joca.2026.09.007_bib78","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/acr.24549","article-title":"Concept End Points Informing Design Considerations for Confirmatory Clinical Trials in Osteoarthritis","volume":"74","author":"Kim","year":"2022","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.joca.2026.09.007_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113842","article-title":"Does receptor balance matter? \u2013 Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models","volume":"156","author":"Larsen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.joca.2026.09.007_bib80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: Results from two phase 3 trials","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.09.007_bib81","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.21873\/invivo.12595","article-title":"Screening Tools for Sarcopenia","volume":"35","author":"Nishikawa","year":"2021","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.joca.2026.09.007_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43019-025-00265-6","article-title":"Sarcopenia: how to determine and manage","volume":"37","author":"Chung","year":"2025","journal-title":"Knee Surg. Relat. Res."},{"key":"10.1016\/j.joca.2026.09.007_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102148","article-title":"Blood biomarkers for sarcopenia: A systematic review and meta-analysis of diagnostic test accuracy studies","volume":"93","author":"Lian","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.joca.2026.09.007_bib84","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.joca.2021.04.018","article-title":"Imaging in Osteoarthritis","volume":"30","author":"Roemer","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.joca.2026.09.007_bib85","article-title":"A novel classifier of radiographic knee osteoarthritis for use on knee DXA images is predictive of joint replacement in UK Biobank","volume":"9","author":"Beynon","year":"2025","journal-title":"Rheumatol. Adv. Pract."},{"key":"10.1016\/j.joca.2026.09.007_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100602","article-title":"Imaging-based measures of synovitis in knee osteoarthritis: A scoping review and narrative synthesis","volume":"7","author":"Dima","year":"2025","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.joca.2026.09.007_bib87","doi-asserted-by":"crossref","first-page":"e1356","DOI":"10.1210\/clinem\/dgab897","article-title":"Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery","volume":"107","author":"Bel Lassen","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.joca.2026.09.007_bib88","doi-asserted-by":"crossref","DOI":"10.1159\/000546489","article-title":"Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney Disease","author":"Vasan","year":"2025","journal-title":"Am. J. Nephrol."}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458426010484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458426010484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:14:57Z","timestamp":1791663297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458426010484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":88,"alternative-id":["S1063458426010484"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2026.09.007","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can obesity pharmacotherapy modify osteoarthritis? Interpreting pain relief, weight-loss quality, and structural outcomes","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}